Furthermore, it addresses the FDA’s communications With all the applicant, the retention of data that help the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer ownership of an SE report to a whole new applicant and electronic submission from the SE report and amendments